SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $11,680,000 | +308.7% | 68,740 | +174.8% | 0.08% | +310.0% |
| Q4 2019 | $2,858,000 | +525.4% | 25,017 | +210.0% | 0.02% | +300.0% |
| Q4 2018 | $457,000 | -79.2% | 8,071 | -80.2% | 0.01% | -68.8% |
| Q3 2016 | $2,197,000 | -43.8% | 40,676 | -59.9% | 0.02% | -66.7% |
| Q3 2015 | $3,911,000 | -30.4% | 101,439 | -12.6% | 0.05% | -34.2% |
| Q2 2015 | $5,617,000 | +1025.7% | 116,061 | +789.7% | 0.07% | +942.9% |
| Q2 2014 | $499,000 | – | 13,045 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |